Australian biotech market today 22.04.09
22 April, 2009 by Kate McDonaldGenetic Technologies, Circadian, Bionomics, Ambri, Hexima, LCT, Pharmaxis, Cellestis, AIC
Bionomics targets throat cancer
22 April, 2009 by Kate McDonaldThroat cancer added to list of targets for VDA, Celera developing proteomics-based lung cancer diagnostic
Solid performance for biotech: PwC
21 April, 2009 by Kate McDonaldLatest PwC BioForum report has unexpected good news, but fundamentals are unchanged
Australian biotech market today 21.04.09
21 April, 2009 by Kate McDonaldNeuren, ChemGenex, Novogen, Biota, Alchemia, Impedimed, Sirtex
QRxPharma hits on right dose
20 April, 2009 by Kate McDonaldQRxPharma completes Phase III dose pilot for opioids
Progen targets epigenetics
20 April, 2009 by Kate McDonaldProgen working on polyamine analogues for DNA demethylases, cell proliferation
Fermiscan and Polartechnics to merge
20 April, 2009 by Kate McDonaldTwo Sydney diagnostics company to form Novus Diagnostics
Fight of the honeybees
16 April, 2009 by Kate McDonaldSpanish researchers may have found a cure for honeybee colony collapse disorder
Australian biotech market today 15.04.09
15 April, 2009 by Kate McDonaldAcrux, Atcor, Cellestis, Pharmaxis, Mesoblast, Circadian, Alchemia
Acuvax cashes in RESprotect
15 April, 2009 by Kate McDonaldAcuvax divests small holding in German developer of pancreatic cancer drug
Australian biotech market today 14.04.09
14 April, 2009 by Kate McDonaldCellestis, ChemGenex, Mesoblast, Pharmaxis, Novogen, Probiotec, LabTech Systems
Canadian swine for Stirling
14 April, 2009 by Kate McDonaldStirling Products signs Canadian research agreement for R-salbutamol
Australian biotech market today 09.04.09
09 April, 2009 by Kate McDonaldGenera Biosystems, ChemGenex, Pharmaxis, LCT, pSivida, Bionomics, Mesoblast
How will biotech survive the GFC?
09 April, 2009 by Kate McDonaldThe biotechnology industry is in crisis on a global scale, so what can the industry do to help itself, and is government going to come to the rescue?
